PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-May-2024 Global Fertility and Pregnancy Rapid Test Kit Market Set to Flourish, Expected to Reach US$ 1,609.1 Million by 2033 at a 5% CAGR MARKITWIRED
01-May-2024 Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health Viatris
01-May-2024 Cytomos offers sneak preview of flagship technology at the London Biotechnology Show 2024 Cytomos
01-May-2024 MindBio Is Exploring Dual Listing on A Senior Exchange with Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3 AccessWire
01-May-2024 SYGNATURE DISCOVERY RECEIVES ECOVADIS AWARD FOR SUSTAINABLE EXCELLENCE SYGNATURE DISCOVERY
01-May-2024 Ardena's Nanomedicines Facility Marks €20 Million Expansion with first GMP approval Ardena
01-May-2024 Bioz and Copan Diagnostics Release AI-Based Citation Tools for Researchers AccessWire
01-May-2024 Genflow Biosciences PLC Announces Temporary Suspension AccessWire
01-May-2024 Vitruvia Medical AG: Year End results as of December 31, 2023 Vitruvia Medical AG
01-May-2024 Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA AccessWire
01-May-2024 MedMira Announces the Hire of Vice President of Business Development AccessWire
30-Apr-2024 Vita 34 returns to growth path in 2023 Vita 34 AG
30-Apr-2024 Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024 AccessWire
30-Apr-2024 Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024.  Spexis AG
30-Apr-2024 Beckman Coulter Life Sciences and Watchmaker Genomics Announce Partnership Beckman Coulter Life Sciences
30-Apr-2024 Bioscript Group acquires Enzyme Communications to bolster its medical writing, scientific content creation and storytelling capabilities Bioscript Group
30-Apr-2024 Transformative partnership between the Medicines Patent Pool and ViiV Healthcare enables 24 million people in low- and middle-income countries to access innovative HIV treatment ViiV Healthcare
30-Apr-2024 Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision ImmunomicsTM antigen discovery technologies to target five more cancers Infinitopes Precision Immunomics
30-Apr-2024 AlayaCare Selected by ParaMed as Technology Platform to Power Home Health Care Across Canada AccessWire
30-Apr-2024 Poolbeg Pharma plc - Results for the year ended 31 December 2023 Poolbeg Pharma plc